Dr. Croghan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2625 N Craycroft Rd
Ste 100
Tucson, AZ 85712Phone+1 520-324-4214Fax+1 520-324-2680
Education & Training
- University of Arizona College of Medicine-TucsonResidency, Radiation Oncology, 1988 - 1991
- University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1985 - 1988
- University of WashingtonResidency, Internal Medicine, 1982 - 1985
- University of Washington School of MedicineClass of 1982
Certifications & Licensure
- AZ State Medical License 1985 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2014
Publications & Presentations
PubMed
- 12 citationsPhase I study of low-dose cyclophosphamide and recombinant interleukin-2 for the treatment of advanced cancer.Christopher J. Verdi, Charles W. Taylor, Marilyn K. Croghan, Patricia Dalke, Frank L. Meyskens
Journal of Immunotherapy. 1992-05-01 - 29 citationsDose-related alpha-difluoromethylornithine ototoxicity.Marilyn K. Croghan, Mikel Aickin, Frank L. Meyskens
American Journal of Clinical Oncology. 1991-08-01 - 8 citationsA phase I trial of recombinant interferon-alpha and alpha-difluoromethylornithine in metastatic melanoma.Marilyn K. Croghan, Ann R. Booth, Frank L. Meyskens
Journal of Biological Response Modifiers. 1988-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: